🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, double-dummy, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-04-04
Trial ID
NCT01822899
The objective of this study is to evaluate the efficacy and safety of vilan...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-01
Trial ID
NCT01181895
This is a multicenter, randomized, double-blind, double-dummy, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-03-01
Trial ID
NCT01817764
Treatments Being Tested
This will be a Phase IIIb multicentre, randomized, double-blind, double-dum...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-15
Trial ID
NCT01706328
Umeclidinium/vilanterol (UMEC/VI) is a combination product under developmen...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-13
Trial ID
NCT01879410
Studies to date provides substantial evidence for the effectiveness for UME...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05-09
Trial ID
NCT02184611
Treatments Being Tested
A randomised, double-blind, placebo-controlled, parallel group multicentre ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01
Trial ID
NCT01498679
Treatments Being Tested
This is a Phase IIb, multi-centre, randomised, double-blind, parallel-group...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04
Trial ID
NCT01573767
Treatments Being Tested
This is a multicentre, randomized, blinded, double dummy, parallel group st...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-01
Trial ID
NCT02207829
Treatments Being Tested